|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 25, 2016 ) After entering China, recombinant factor ? develops fast with annual sales value rising from less than CNY 6 million in 2009 to CNY 93.78 million in 2014 and CAGR reaching up to 76.8% during 2009-2014. Currently, recombinant factor ? in the Chinese market are all imported drugs. They mainly come from the following three companies: Baxter Bioscience Manufacturing (SW), Wyeth Farma S.A. (SP) and Bayer (the US), among which Bayer (the US) has the largest market share of 57.40% by sales value in 2014.
As hemophiliacs’ ability to pay for medical treatment keeps increasing due to economic development, the market size of recombinant factor ? in China is expected to keep expanding.
Request sample at : https://marketreportscenter.com/request-sample/133381
Readers can get at least the following information from this report:
-sales status of recombinant factor ? in China
-price of recombinant factor ? in Chinese market
-major manufacturers of recombinant factor ? in Chinese market
-share of dosage forms of recombinant factor ? in China
-market outlook of recombinant factor ? in China
Check for Discount at : https://marketreportscenter.com/request-discount/133381
The author suggests the following groups of people purchase this report:
-manufacturers of blood products
-investors/ research institutions interested in China blood products market
-any interest in the Chinese medicine market, please contact CRI for customized survey service
Browse full report with TOC : https://marketreportscenter.com/reports/133381/investigation-report-on-china-recombinant-factor-market-2010-2019
Connect for more details:
Sam Collins
Market Reports Center
Call us : 1-646-883-3044 (US)
Email : info@marketreportscenter.com
visit our website : https://marketreportscenter.com
Market Reports Center
Sam Collins
1-646-883-3044
sam@marketreportscenter.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
